JNJ-41876666

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameJNJ-41876666
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionTransient receptor potential cation channel subfamily M member 8 antagonists
TargetsTransient receptor potential cation channel subfamily M member 8
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Pharmaceutical Research & Development LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson Pharmaceutical Research & Development LLC
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A